Plunkett Research Online: AngioSoma

ANGIOSOMA (SOAN:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AngioSoma Inc is a US-based clinical-stage biotechnology company. It focuses on improving the effectiveness of current standard-of-care treatments, especially related to endovascular interventions in the treatment of peripheral artery disease (PAD). The company is engaged in developing its lead prod.....



AngioSoma
Ticker: SOAN
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 832 781-8521
Fax:
Address: 2500 Wilcrest Drive, 3rd Floor
Houston, TX 77042 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
G. PinaDirector/CEO/President
AngioSoma Inc is a US-based clinical-stage biotechnology company. It focuses on improving the effectiveness of current standard-of-care treatments, especially related to endovascular interventions in the treatment of peripheral artery disease (PAD). The company is engaged in developing its lead prod.....See More See More

Auditor: M&K CPAS, PLLC
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: